# Official Journal C 196/2013

| | ISSN 1977-091X
  doi:10.3000/1977091X.C_2013.196.eng |
| --- | --- |
| Official Journal
  of the European Union | C 196 |
| | |
| English edition | Information and Notices | Volume 569 July 2013 |

ISSN 1977-091X

doi:10.3000/1977091X.C_2013.196.eng

Official Journal

of the European Union

C 196

English edition

Information and Notices

Volume 569 July 2013

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2013/C 196/01 | Non-opposition to a notified concentration (Case COMP/M.6883 — Canada Life/Irish Life) (
  1
  ) | 1 |
| 2013/C 196/02 | Non-opposition to a notified concentration (Case COMP/M.6897 — Shell/Repsol (major part of LNG business)) (
  1
  ) | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2013/C 196/01

Non-opposition to a notified concentration (Case COMP/M.6883 — Canada Life/Irish Life) (
  1
  )

1

1

2013/C 196/02

Non-opposition to a notified concentration (Case COMP/M.6897 — Shell/Repsol (major part of LNG business)) (
  1
  )

1

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2013/C 196/03 | Euro exchange rates | 2 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2013/C 196/03

Euro exchange rates

2

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2013/C 196/04 | Prior notification of a concentration (Case COMP/M.6969 — Valeant Pharmaceuticals International/Bausch & Lomb Holdings) (
  1
  ) | 3 |
| 2013/C 196/05 | Prior notification of a concentration (Case COMP/M.6963 — Archer-Daniels-Midland Company/GrainCorp) — Candidate case for simplified procedure (
  1
  ) | 4 |
| 2013/C 196/06 | Prior notification of a concentration (Case COMP/M.6934 — Norges Bank/Generali/Group of buildings in Paris) — Candidate case for simplified procedure (
  1
  ) | 5 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2013/C 196/04

Prior notification of a concentration (Case COMP/M.6969 — Valeant Pharmaceuticals International/Bausch & Lomb Holdings) (
  1
  )

1

3

2013/C 196/05

Prior notification of a concentration (Case COMP/M.6963 — Archer-Daniels-Midland Company/GrainCorp) — Candidate case for simplified procedure (
  1
  )

1

4

2013/C 196/06

Prior notification of a concentration (Case COMP/M.6934 — Norges Bank/Generali/Group of buildings in Paris) — Candidate case for simplified procedure (
  1
  )

1

5

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 9.7.2013 | EN | Official Journal of the European Union | C 196/1 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/1

---

Non-opposition to a notified concentration

(Case COMP/M.6883 — Canada Life/Irish Life)

(Text with EEA relevance)

2013/C 196/01

On 31 May 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6883. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6883. EUR-Lex is the on-line access to the European law.

---

| 9.7.2013 | EN | Official Journal of the European Union | C 196/1 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/1

---

Non-opposition to a notified concentration

(Case COMP/M.6897 — Shell/Repsol (major part of LNG business))

(Text with EEA relevance)

2013/C 196/02

On 2 July 2013, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6897. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32013M6897. EUR-Lex is the on-line access to the European law.

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 9.7.2013 | EN | Official Journal of the European Union | C 196/2 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/2

---

Euro exchange rates (1)

8 July 2013

2013/C 196/03

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2850 |
| JPY | Japanese yen | 130,04 |
| DKK | Danish krone | 7,4594 |
| GBP | Pound sterling | 0,86160 |
| SEK | Swedish krona | 8,7898 |
| CHF | Swiss franc | 1,2404 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,9650 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,938 |
| HUF | Hungarian forint | 294,52 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7021 |
| PLN | Polish zloty | 4,2959 |
| RON | Romanian leu | 4,4483 |
| TRY | Turkish lira | 2,5025 |
| AUD | Australian dollar | 1,4145 |
| CAD | Canadian dollar | 1,3567 |
| HKD | Hong Kong dollar | 9,9662 |
| NZD | New Zealand dollar | 1,6573 |
| SGD | Singapore dollar | 1,6470 |
| KRW | South Korean won | 1 475,65 |
| ZAR | South African rand | 13,0845 |
| CNY | Chinese yuan renminbi | 7,8818 |
| HRK | Croatian kuna | 7,5180 |
| IDR | Indonesian rupiah | 12 793,67 |
| MYR | Malaysian ringgit | 4,1144 |
| PHP | Philippine peso | 56,129 |
| RUB | Russian rouble | 42,7520 |
| THB | Thai baht | 40,413 |
| BRL | Brazilian real | 2,8916 |
| MXN | Mexican peso | 16,7461 |
| INR | Indian rupee | 78,0700 |

Currency

Exchange rate

USD

US dollar

1,2850

JPY

Japanese yen

130,04

DKK

Danish krone

7,4594

GBP

Pound sterling

0,86160

SEK

Swedish krona

8,7898

CHF

Swiss franc

1,2404

ISK

Iceland króna

NOK

Norwegian krone

7,9650

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,938

HUF

Hungarian forint

294,52

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7021

PLN

Polish zloty

4,2959

RON

Romanian leu

4,4483

TRY

Turkish lira

2,5025

AUD

Australian dollar

1,4145

CAD

Canadian dollar

1,3567

HKD

Hong Kong dollar

9,9662

NZD

New Zealand dollar

1,6573

SGD

Singapore dollar

1,6470

KRW

South Korean won

1 475,65

ZAR

South African rand

13,0845

CNY

Chinese yuan renminbi

7,8818

HRK

Croatian kuna

7,5180

IDR

Indonesian rupiah

12 793,67

MYR

Malaysian ringgit

4,1144

PHP

Philippine peso

56,129

RUB

Russian rouble

42,7520

THB

Thai baht

40,413

BRL

Brazilian real

2,8916

MXN

Mexican peso

16,7461

INR

Indian rupee

78,0700

---

(1)  Source: reference exchange rate published by the ECB.

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 9.7.2013 | EN | Official Journal of the European Union | C 196/3 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/3

---

Prior notification of a concentration

(Case COMP/M.6969 — Valeant Pharmaceuticals International/Bausch & Lomb Holdings)

(Text with EEA relevance)

2013/C 196/04

| 1. | On 1 July 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Valeant Pharmaceuticals International, Inc. (‘Valeant’), a publicly held company established under the laws of Canada, acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Bausch & Lomb Holdings Incorporated (‘Bausch & Lomb’), a privately held company headquartered in Rochester, NY, USA, by way of purchase of shares. |
| --- | --- |

1.

On 1 July 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Valeant Pharmaceuticals International, Inc. (‘Valeant’), a publicly held company established under the laws of Canada, acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Bausch & Lomb Holdings Incorporated (‘Bausch & Lomb’), a privately held company headquartered in Rochester, NY, USA, by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Valeant: development, manufacturing and marketing of specialty pharmaceutical products primarily in the areas of dermatology, neurology and branded generics, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Valeant: development, manufacturing and marketing of specialty pharmaceutical products primarily in the areas of dermatology, neurology and branded generics,

| — | for Bausch & Lomb: development, manufacturing and marketing of ophthalmic, surgical and consumer vision products. |
| --- | --- |

—

for Bausch & Lomb: development, manufacturing and marketing of ophthalmic, surgical and consumer vision products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6969 — Valeant Pharmaceuticals International/Bausch & Lomb Holdings, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6969 — Valeant Pharmaceuticals International/Bausch & Lomb Holdings, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

---

| 9.7.2013 | EN | Official Journal of the European Union | C 196/4 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/4

---

Prior notification of a concentration

(Case COMP/M.6963 — Archer-Daniels-Midland Company/GrainCorp)

Candidate case for simplified procedure

(Text with EEA relevance)

2013/C 196/05

| 1. | On 28 June 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Archer-Daniels-Midland (‘ADM’, US) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the undertaking GrainCorp Limited (‘GrainCorp’, Australia), by way of purchase of shares. |
| --- | --- |

1.

On 28 June 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Archer-Daniels-Midland (‘ADM’, US) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the undertaking GrainCorp Limited (‘GrainCorp’, Australia), by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | ADM is a processor of oilseeds, corn, wheat, cocoa and other agricultural commodities and is a major manufacturer of vegetable oil, protein meal, corn sweeteners, flour, biodiesel, ethanol and other value added food and feed ingredients. ADM also has a global transportation network to procure, store, clean and transport agricultural commodities such as oilseeds, corn, wheat, milo, oats and barley as well as processed agricultural commodities, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

ADM is a processor of oilseeds, corn, wheat, cocoa and other agricultural commodities and is a major manufacturer of vegetable oil, protein meal, corn sweeteners, flour, biodiesel, ethanol and other value added food and feed ingredients. ADM also has a global transportation network to procure, store, clean and transport agricultural commodities such as oilseeds, corn, wheat, milo, oats and barley as well as processed agricultural commodities,

| — | GrainCorp is a company with storage, handling and port operations on Australia’s east coast. GrainCorp is a global malt producer with operations in Australia, North America and Europe. It also markets grains and oilseeds worldwide including in the EEA. |
| --- | --- |

—

GrainCorp is a company with storage, handling and port operations on Australia’s east coast. GrainCorp is a global malt producer with operations in Australia, North America and Europe. It also markets grains and oilseeds worldwide including in the EEA.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6963 — Archer-Daniels-Midland Company/GrainCorp, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6963 — Archer-Daniels-Midland Company/GrainCorp, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

---

| 9.7.2013 | EN | Official Journal of the European Union | C 196/5 |
| --- | --- | --- | --- |

9.7.2013

EN

Official Journal of the European Union

C 196/5

---

Prior notification of a concentration

(Case COMP/M.6934 — Norges Bank/Generali/Group of buildings in Paris)

Candidate case for simplified procedure

(Text with EEA relevance)

2013/C 196/06

| 1. | On 1 July 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking NBIM Clement SCI, an indirectly wholly owned subsidiary of Norges Bank (Norway) acquires within the meaning of Article 3(1)(b) of the Merger Regulation joint control over SCI Pasquier, SCI Malesherbes, SCI Daumesnil, SCI 15 Scribe and SAS 100 CE, (together ‘The Target’, France) together with Assicurazioni Generali (Italy) by the way of acquisition of shares. |
| --- | --- |

1.

On 1 July 2013, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking NBIM Clement SCI, an indirectly wholly owned subsidiary of Norges Bank (Norway) acquires within the meaning of Article 3(1)(b) of the Merger Regulation joint control over SCI Pasquier, SCI Malesherbes, SCI Daumesnil, SCI 15 Scribe and SAS 100 CE, (together ‘The Target’, France) together with Assicurazioni Generali (Italy) by the way of acquisition of shares.

| 2. | The business activities of the undertakings concerned are:






  — | Norges Bank group is the Norwegian central bank, also responsible for managing Norway's foreign exchange reserves and the Government Pension Fund Global, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Norges Bank group is the Norwegian central bank, also responsible for managing Norway's foreign exchange reserves and the Government Pension Fund Global,

| — | Assicurazioni Generali is an insurance group, |
| --- | --- |

—

Assicurazioni Generali is an insurance group,

| — | The Target consists of five properties in Paris. |
| --- | --- |

—

The Target consists of five properties in Paris.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6934 — Norges Bank/Generali/Group of buildings in Paris, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6934 — Norges Bank/Generali/Group of buildings in Paris, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

---